Lawrence F. Eichenfield, MD - Rady Children's Hospital

More documents

Recommendations

Info

Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.41. Pimecrolimus in clinical practice: guidelines for use. Eichenfield LF. Ann Dermatol Venereol2002; 129:1S81-1S141 (Abstract).42. 5% 5-fluorouracil cream for the treatment of common warts in children. Gladsjo JA, Alio A,Kricorian G, Bergman JN, Friedlander SF, Eichenfield LF, Dohil M, Funk A, Holland SE,Cunningham BB. American Academy of Dermatology Summer Meeting 2004. New York, NY(Poster).43. A pilot, randomized, double-blind, vehicle-controlled parallel-group, multicenter study todetermine the safety and efficacy of concomitant use of locoid lipocream cream in Elidelcream-treated subjects with mild to moderate atopic dermatitis. Schachner L, Eichenfield LF,Smith S, Dromgoole S. American Academy of Dermatology Annual Meeting. February 18-22,2005 (Poster).44. An open-label, adrenal suppression study of hydrocortisone butyrate 0.1% lipocream used threetimes daily in children 5-12 years old with moderate to severe eczema or atopic dermatitis.Eichenfield LF, Ellis C, Fivenson D, Hebert A. American Academy of Dermatology AnnualMeeting. February 18-22, 2005 (Poster).45. Fluticasone propionate (FP) emulsion (0.05%): an advance in topical preparations. Miller BH,Eichenfield LF. American Academy of Dermatology Annual Meeting. February 18-22, 2005(Abstract).46. An open-label, adrenal suppression study of hydrocortisone butyrate 0.1% lipocream used threetimes daily in children 5-12 yrs old with moderate to severe eczema or atopic dermatitis.Eichenfield LF. American Academy of Dermatology Annual Meeting. February 18-22, 2005(Poster).47. Pulmonary thromboembolism associated with Klippel-Trenaunay syndrome. Huiras EE, BarnesCJ, Eichenfield, LF, Pelech AN, Drolet BA.Pediatrics 2005;116:e596-e600. URL:www.pediatrics.org/cgi/doi/10.1542/peds.2004-1607 (Abstract).48. Chiang C, Eichenfield LF. Quantitative measurement of bathing and moisturizer inducedchanges in skin hydration in atopic dermatitis subjects. Society for Investigative Dermatology.Philadelphia. May, 2006 (Abstract and Poster).49. Safety of desonide gel, 0.05% in a hypothalamic-pituitary-adrenal axis suppression study ofchildren with atopic dermatitis. American Academy of Pediatrics. Atlanta. October, 2006(Abstract).50. Clindamycin phosphate foam, 1% for the treatment of acne vulgaris: subanalysis in adolescents.American Academy of Pediatrics. Atlanta. October, 2006.------------------------------51. Comparative absorption of 0.25% and 2% miconazole nitrate preparations in infants withdiaper dermatitis. American Academy of Dermatology Annual Meeting. Washington, DC.February, 2007 (Abstract & Poster accepted).52. A randomized, double blind, placebo controlled, parallel group study of nanocrystalline silver(NPI 32101) cream in pediatric atopic dermatitis (AD). American Academy of DermatologyAnnual Meeting. Washington, DC. February, 2007 (Abstract and Poster accepted).Page 34 of 69
Curriculum VitaeAugust 2012Lawrence F. Eichenfield, M.D.53. The demographic profile of a large population of infants with atopic dermatitis: a longitudinalstudy on the development of asthma and allergies. American Academy of Dermatology AnnualMeeting. Washington, DC. February, 2007 (Abstract and Poster accepted).54. A novel gel formulation of 0.025% tretinoin and 1.2% clindamycin phosphate: efficacy in acnevulgaris patients aged 12 to 18 years. Society for Pediatric Dermatology Annual Meeting.Chicago, IL. July, 2007 (Abstract and Poster accepted).55. An innovative approach to flare prevention and long-term disease control in pediatric patientswith atopic dermatitis: three times weekly applications of tacrolimus ointment . Society forPediatric Dermatology Annual Meeting. Chicago, IL. July, 2007 (Abstract and Posteraccepted).56. Baseline atopic dermatitis profile of over 1000 infants enrolled into a study assessing the effectof pimecrolimus cream 1% on atopic dermatitis and development of asthma and allergies. 21stWorld Congress of Dermatology. Buenos Aires, Argentina. September 30-October 5, 2007(Abstract and Poster accepted).57. A multicenter, double-blind, vehicle-controlled clinical study to evaluate the efficacy andtolerability of MAS063DP (atopiclair/zarzenda) in the management of mile to moderate atopicdermatitis in children and infants. 21st World Congress of Dermatology. September 30 –October 5, 2007 (Abstract accepted).58. Etanercept treatment in children and adolescents with plaque psoriasis. American Academy ofDermatology Annual Meeting. January 31 – February 4, 2008 (Abstract and Poster accepted).59. An innovative approach to flare prevention and long-term disease control in pediatric patientswith atopic dermatitis: three-times weekly applications of tacrolimus ointment. 9th Congress ofthe European Society for Pediatric Dermatology (ESPD). Athens, Greece (Abstract submitted).60. Long-term intermittent use of tacrolimus ointment for flare prevention and disease control inpediatric patients with stabilized atopic dermatitis. American Academy of Dermatology AnnualMeeting. January 31 – February 4, 2008 (Abstract and Poster accepted).61. An open-label, community-based, phase four study to assess facial acne improvement with theuse of tretinoin gel microsphere in a pump dispenser. American Academy of DermatologyAnnual Meeting. January 31 – February 4, 2008 (Abstract and Poster accepted).62. DermBridge: developing a core dermatological curriculum for the next generation ofphysicians. American Academy of Dermatology Annual Meeting. January 31 – February 4,2008 (Abstract and Poster accepted).63. Comparison of a 3-step acne system containing solubilized benzoyl peroxide versus benzoylperoxide/clindamycin: a multicenter, investigator-blind, randomized study. American Academyof Dermatology Annual Meeting. January 31 – February 4, 2008 (Abstract and Posteraccepted).64. Etanercept treatment in children and adolescents with plaque psoriasis. Winter ClinicalDermatology Conference. March 14-18, 2008 (Poster Submitted).65. Epiceram for the treatment of mild-moderate atopic dermatitis – a pilot study. Posterpresentation. 5th George Rajka International Symposium of Atopic Dermatitis, Kyoto, Japan.May, 2008.Page 35 of 69
Page 3 and 4: Curriculum VitaeAugust 2012Lawrence
Page 6 and 7: Curriculum VitaeAugust 2012Graduate
Page 12 and 13: Curriculum VitaeAugust 2012Physicia
Page 62 and 63: Curriculum VitaeAugust 2012Sarah Hi
Page 64 and 65: Curriculum VitaeAugust 2012Laurie B

Lawrence F. Eichenfield, MD - Rady Children's Hospital

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?